LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article: Rapid literature review: definition and methodology.

    Smela, Beata / Toumi, Mondher / Świerk, Karolina / Francois, Clement / Biernikiewicz, Małgorzata / Clay, Emilie / Boyer, Laurent

    Journal of market access & health policy

    2023  Volume 11, Issue 1, Page(s) 2241234

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2023-07-28
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2001-6689
    ISSN 2001-6689
    DOI 10.1080/20016689.2023.2241234
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Systematic literature reviews over the years.

    Smela, Beata / Toumi, Mondher / Świerk, Karolina / Gawlik, Konrad / Clay, Emilie / Boyer, Laurent

    Journal of market access & health policy

    2023  Volume 11, Issue 1, Page(s) 2244305

    Abstract: Purpose: ...

    Abstract Purpose:
    Language English
    Publishing date 2023-08-21
    Publishing country United States
    Document type Journal Article
    ISSN 2001-6689
    ISSN 2001-6689
    DOI 10.1080/20016689.2023.2244305
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Correction: Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression.

    Pierson Smela, Merrick D / Kramme, Christian C / Fortuna, Patrick R J / Adams, Jessica L / Su, Alina Rui / Dong, Edward / Kobayashi, Mutsumi / Brixi, Garyk / Kavirayuni, Venkata Srikar / Tysinger, Emma / Kohman, Richie E / Shioda, Toshi / Chatterjee, Pranam / Church, George M

    eLife

    2023  Volume 12

    Language English
    Publishing date 2023-03-22
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.87987
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression.

    Pierson Smela, Merrick D / Kramme, Christian C / Fortuna, Patrick R J / Adams, Jessica L / Su, Rui / Dong, Edward / Kobayashi, Mutsumi / Brixi, Garyk / Kavirayuni, Venkata Srikar / Tysinger, Emma / Kohman, Richie E / Shioda, Toshi / Chatterjee, Pranam / Church, George M

    eLife

    2023  Volume 12

    Abstract: An in vitro model of human ovarian follicles would greatly benefit the study of female reproduction. Ovarian development requires the combination of germ cells and several types of somatic cells. Among these, granulosa cells play a key role in follicle ... ...

    Abstract An in vitro model of human ovarian follicles would greatly benefit the study of female reproduction. Ovarian development requires the combination of germ cells and several types of somatic cells. Among these, granulosa cells play a key role in follicle formation and support for oogenesis. Whereas efficient protocols exist for generating human primordial germ cell-like cells (hPGCLCs) from human induced pluripotent stem cells (hiPSCs), a method of generating granulosa cells has been elusive. Here, we report that simultaneous overexpression of two transcription factors (TFs) can direct the differentiation of hiPSCs to granulosa-like cells. We elucidate the regulatory effects of several granulosa-related TFs and establish that overexpression of NR5A1 and either RUNX1 or RUNX2 is sufficient to generate granulosa-like cells. Our granulosa-like cells have transcriptomes similar to human fetal ovarian cells and recapitulate key ovarian phenotypes including follicle formation and steroidogenesis. When aggregated with hPGCLCs, our cells form ovary-like organoids (ovaroids) and support hPGCLC development from the premigratory to the gonadal stage as measured by induction of DAZL expression. This model system will provide unique opportunities for studying human ovarian biology and may enable the development of therapies for female reproductive health.
    MeSH term(s) Humans ; Female ; Transcription Factors/metabolism ; Induced Pluripotent Stem Cells ; Ovary/metabolism ; Oogenesis ; Cell Differentiation
    Chemical Substances Transcription Factors
    Language English
    Publishing date 2023-02-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.83291
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: High resolution monitoring of chemotherapeutic agent potency in cancer cells using a CMOS capacitance biosensor.

    Senevirathna, Bathiya / Lu, Sheung / Dandin, Marc / Basile, John / Smela, Elisabeth / Abshire, Pamela

    Biosensors & bioelectronics

    2019  Volume 142, Page(s) 111501

    Abstract: Monitoring cell viability and proliferation in real-time provides a more comprehensive picture of the changes cells undergo during their lifecycle than can be achieved using traditional end-point assays. Particularly for drug screening applications, high- ...

    Abstract Monitoring cell viability and proliferation in real-time provides a more comprehensive picture of the changes cells undergo during their lifecycle than can be achieved using traditional end-point assays. Particularly for drug screening applications, high-temporal resolution cell viability data could inform decisions on drug application protocols that might lead to better treatment outcomes. We describe a CMOS biosensor that monitors cell viability through high-resolution capacitance measurements of cell adhesion quality. The system consists of a 3 × 3 mm
    MeSH term(s) Antineoplastic Agents/pharmacology ; Biosensing Techniques/instrumentation ; Cell Death/drug effects ; Cell Line, Tumor ; Cisplatin/pharmacology ; Drug Screening Assays, Antitumor/instrumentation ; Electric Capacitance ; Equipment Design ; Female ; Humans ; Lab-On-A-Chip Devices ; Ovarian Neoplasms/drug therapy
    Chemical Substances Antineoplastic Agents ; Cisplatin (Q20Q21Q62J)
    Language English
    Publishing date 2019-07-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 1011023-9
    ISSN 1873-4235 ; 0956-5663
    ISSN (online) 1873-4235
    ISSN 0956-5663
    DOI 10.1016/j.bios.2019.111501
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A novel surface modification technique for forming porous polymer monoliths in poly(dimethylsiloxane).

    Burke, Jeffrey M / Smela, Elisabeth

    Biomicrofluidics

    2012  Volume 6, Issue 1, Page(s) 16506–1650610

    Abstract: A new method of surface modification is described for enabling the in situ formation of homogenous porous polymer monoliths (PPMs) within poly(dimethylsiloxane) (PDMS) microfluidic channels that uses 365 nm UV illumination for polymerization. Porous ... ...

    Abstract A new method of surface modification is described for enabling the in situ formation of homogenous porous polymer monoliths (PPMs) within poly(dimethylsiloxane) (PDMS) microfluidic channels that uses 365 nm UV illumination for polymerization. Porous polymer monolith formation in PDMS can be challenging because PDMS readily absorbs the monomers and solvents, changing the final monolith morphology, and because PDMS absorbs oxygen, which inhibits free-radical polymerization. The new approach is based on sequentially absorbing a non-hydrogen-abstracting photoinitiator and the monomers methyl methacrylate and ethylene diacrylate within the walls of the microchannel, and then polymerizing the surface treatment polymer within the PDMS, entangled with it but not covalently bound. Four different monolith compositions were tested, all of which yielded monoliths that were securely anchored and could withstand pressures exceeding the bonding strength of PDMS (40 psi) without dislodging. One was a recipe that was optimized to give a larger average pore size, required for low back pressure. This monolith was used to concentrate and subsequently mechanical lyse B lymphocytes.
    Language English
    Publishing date 2012-03-09
    Publishing country United States
    Document type Journal Article
    ISSN 1932-1058
    ISSN (online) 1932-1058
    DOI 10.1063/1.3693589
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.

    Beck, Ekkehard / Biundo, Eliana / Devlin, Nancy / Doherty, T Mark / Garcia-Ruiz, Antonio J / Postma, Maarten / Sheikh, Shazia / Smela, Beata / Toumi, Mondher / Wasem, Jurgen / Nolan, Terry / Salisbury, David

    Vaccine

    2022  Volume 40, Issue 30, Page(s) 4008–4016

    Abstract: ... The dimensions were: (I) conventional payer perspective concepts (e.g., health gains in vaccinees, direct medical ... costs); (II) conventional societal perspective concepts (e.g., indirect health/economic gains ... to caregivers/households, productivity in vaccinees); and (III) novel societal concepts (e.g., financial risk ...

    Abstract Background: Vaccination provides significant health gains to individuals and society and can potentially improve health equity, healthcare systems and national economies. Policy decisions, however, are rarely informed by comprehensive economic evaluations (EE) including vaccination's wide-ranging value. The objective of this analysis was to focus on health technology assessment systems to identify relevant value concepts in order to improve current EE of non-pandemic vaccines.
    Methods: Following a literature review, a novel Value of Vaccination (VoV) framework was developed with experts in vaccine EE from developed countries with established health technology assessment systems.
    Results: Forty-four studies presenting value frameworks or concepts applicable to vaccination were included. Eighteen unique value concepts relevant to EE were identified and defined. These were categorised within the VoV framework using three dimensions, moving from a narrow payer perspective to a more expansive and societal perspective. The dimensions were: (I) conventional payer perspective concepts (e.g., health gains in vaccinees, direct medical costs); (II) conventional societal perspective concepts (e.g., indirect health/economic gains to caregivers/households, productivity in vaccinees); and (III) novel societal concepts (e.g., financial risk protection, peace of mind, societal health gains, healthcare systems security, political stability, social equity and macroeconomic gains). While good quality evidence and methods are available to support concepts in Dimensions I and II, further work is needed to generate the required evidence for vaccination impact on Dimension III concepts.
    Conclusions: The devastating effect on nations of the COVID-19 pandemic has helped to highlight the potential far-reaching benefits that many vaccination programmes can offer. This VoV framework is particularly relevant to policy decisions considering EE, and the potential future expansion of non-pandemic vaccination value considerations. The framework helps to understand and compare current value considerations across countries and payer versus societal perspectives. It provides decision-makers with a transparent and logical path to broaden consideration of VoV in EE.
    MeSH term(s) COVID-19/prevention & control ; Cost-Benefit Analysis ; Humans ; Pandemics/prevention & control ; Technology Assessment, Biomedical ; Vaccination ; Vaccines
    Chemical Substances Vaccines
    Language English
    Publishing date 2022-05-23
    Publishing country Netherlands
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2022.04.050
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: MegaGate: A toxin-less gateway molecular cloning tool.

    Kramme, Christian / Plesa, Alexandru M / Wang, Helen H / Wolf, Bennett / Smela, Merrick Pierson / Guo, Xiaoge / Kohman, Richie E / Chatterjee, Pranam / Church, George M

    STAR protocols

    2021  Volume 2, Issue 4, Page(s) 100907

    Abstract: Gateway cloning employs the use of ... ...

    Abstract Gateway cloning employs the use of the
    MeSH term(s) Cloning, Molecular/methods ; DNA, Complementary/genetics ; Escherichia coli/genetics ; Gene Library ; Plasmids/genetics ; Polymerase Chain Reaction/methods ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism
    Chemical Substances DNA, Complementary ; Recombinant Fusion Proteins
    Language English
    Publishing date 2021-10-22
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2666-1667
    ISSN (online) 2666-1667
    DOI 10.1016/j.xpro.2021.100907
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: An integrated pipeline for mammalian genetic screening.

    Kramme, Christian / Plesa, Alexandru M / Wang, Helen H / Wolf, Bennett / Smela, Merrick Pierson / Guo, Xiaoge / Kohman, Richie E / Chatterjee, Pranam / Church, George M

    Cell reports methods

    2021  Volume 1, Issue 6, Page(s) 100082

    Abstract: With the recent advancements in genome editing, next-generation sequencing (NGS), and scalable cloning techniques, scientists can now conduct genetic screens at unprecedented levels of scale and precision. With such a multitude of technologies, there is ... ...

    Abstract With the recent advancements in genome editing, next-generation sequencing (NGS), and scalable cloning techniques, scientists can now conduct genetic screens at unprecedented levels of scale and precision. With such a multitude of technologies, there is a need for a simple yet comprehensive pipeline to enable systematic mammalian genetic screening. In this study, we develop unique algorithms for target identification and a toxin-less Gateway cloning tool, termed MegaGate, for library cloning which, when combined with existing genetic perturbation methods and NGS-coupled readouts, enable versatile engineering of relevant mammalian cell lines. Our integrated pipeline for sequencing-based target ascertainment and modular perturbation screening (STAMPScreen) can thus be utilized for a host of cell state engineering applications.
    MeSH term(s) Animals ; CRISPR-Cas Systems ; Gene Editing ; Mammals/genetics ; Gene Library ; Genetic Testing
    Language English
    Publishing date 2021-09-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2667-2375
    ISSN (online) 2667-2375
    DOI 10.1016/j.crmeth.2021.100082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: High-throughput particle separation and concentration using spiral inertial filtration.

    Burke, Jeffrey M / Zubajlo, Rebecca E / Smela, Elisabeth / White, Ian M

    Biomicrofluidics

    2014  Volume 8, Issue 2, Page(s) 24105

    Abstract: A spiral inertial filtration (SIFT) device that is capable of high-throughput (1 ml/min), high-purity particle separation while concentrating recovered target particles by more than an order of magnitude is reported. This device is able to remove large ... ...

    Abstract A spiral inertial filtration (SIFT) device that is capable of high-throughput (1 ml/min), high-purity particle separation while concentrating recovered target particles by more than an order of magnitude is reported. This device is able to remove large fractions of sample fluid from a microchannel without disruption of concentrated particle streams by taking advantage of particle focusing in inertial spiral microfluidics, which is achieved by balancing inertial lift forces and Dean drag forces. To enable the calculation of channel geometries in the SIFT microsystem for specific concentration factors, an equivalent circuit model was developed and experimentally validated. Large particle concentration factors were then achieved by maintaining either the average fluid velocity or the Dean number throughout the entire length of the channel during the incremental removal of sample fluid. The SIFT device was able to separate MCF7 cells spiked into whole blood from the non-target white blood cells (WBC) with a recovery of nearly 100% while removing 93% of the sample volume, which resulted in a concentration enhancement of the MCF7 cancer cells by a factor of 14.
    Language English
    Publishing date 2014-04-01
    Publishing country United States
    Document type Journal Article
    ISSN 1932-1058
    ISSN 1932-1058
    DOI 10.1063/1.4870399
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top